In Vitro Diagnostics Business Outlook, Volume 3, Issue 4 - Blood Screening
19 Sep 2024
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
- Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
Table of Contents
-
Market Analysis: Focus on Blood Screening Diagnostics
- Overview of Blood Screening
- Market Outlook
-
Regional Market
- Segment Activity by Region
-
Top Company Briefs
- Roche
- Grifols
- Abbott
-
Executive News Briefing
-
Briefs
- Trinity Biotech Engages New CCO
- BillionToOne Closes Financing Deal
- OraSure Technologies Elects New Board Member
- Viome Life Sciences Secures $25 Million in Financing
- Syantra Raises $3.6 Million in A-1 Round Financing
- Dexcom Revenues Increase 15% (+$133 million) in Q2 2024
- Exact Sciences Reports it “Tested a Record Number of Cancer Patients with Oncotype DX”
-
Briefs
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
- Partnerships and Collaborations
- Mergers and Acquisitions
- Region Watch
-
Broad-based Company Announcements
-
Announcements
- Foundation Medicine Gets the Nod for Its Companion Diagnostics
- QuidelOrtho Proud to Announce Clearance for VITROS Syphilis Assay
- AliveDx Receives IVDR-CE Mark for Multiplexed Assay
- T2 Biosystems Scores FDA Pediatric Clearance
- ID-FISH Technology Announces FDA Nod for its Lyme ImmunoBlotFSIGenetic
-
Announcements